Richard C. Malabre, CAO of Akebia Therapeutics AKBA, has filed 0 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $68.8K. The latest trade was on 02/02.

RM

RM

Richard C. Malabre

SVP, Chief Accounting Officer

Company

Akebia Therapeutics AKBA

First filing

24/02/02

Trades

13 trades

Buys / sales

0 / 5

12-month net buying

−$68.8K

Last trade

02/02

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Akebia TherapeuticsAKBA	Open-market sale10b5-1 plan	02/02	02/04	49,524 sh2 trades	$1.39avg.	$68,838.36	−14.2%
Akebia TherapeuticsAKBA	Open-market sale10b5-1 plan	25/06/09	25/06/11	15,000 sh	$4.01	$60,150	−5.3%
Akebia TherapeuticsAKBA	Open-market sale10b5-1 plan	25/06/04	25/06/05	13,334 sh	$3.53	$47,069.02	−4.8%
Akebia TherapeuticsAKBA	Open-market sale10b5-1 plan	25/02/03	25/02/04	30,202 sh	$2.10	$63,424.2	−9.7%